10/7/2020 12:53:22 PM - Hitting yet another new all-time high with today&#39;s 9th consecutive volume-driven gain, very extended from any sound base. The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>9/17/2020 12:17:27 PM - Hitting new all-time high with today&#39;s 8th consecutive volume-driven gain. The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>9/16/2020 12:16:08 PM - Hitting a new all-time high with today&#39;s 7th consecutive volume-driven gain. The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>9/15/2020 12:19:46 PM - Hitting a new all-time high with today&#39;s 6th consecutive volume-driven gain. The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>9/14/2020 12:55:41 PM - Challenging prior highs in the $98 are with today&#39;s big gain, its 5th consecutive gain backed by above average volume. level. The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>9/10/2020 1:20:28 PM - faces resistance due to overhead supply up to the $98 level. The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>9/9/2020 12:30:44 PM - The 4 latest quarterly comparisons through Jun &#39;20 showed earnings versus losses for the year ago periods with strong sales revenues growth.  The UK-based Medical - Products firm has shown losses each year through FY &#39;19, not strong and steady earnings growth over the past 3-5 year as required to meet the A criteria of the fact-based investment system.<br><hr>